Data / Research funding / New York / New York Blood Center
New York Blood Center: 29 NIH awards ($41.6M), fiscal years 2021 to 2026
New York Blood Center in New York, NY is funded under 29 NIH awards ($41.6M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- LXCNYLGGX6N7
- State
- New York
Awards
29 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Complications of Hemolysis and Transfusion Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,413,470 | July 20, 2020 | June 30, 2030 | YAZDANBAKHSH, KARINA | reporter.nih.gov |
| Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,749,095 | August 1, 2021 | May 31, 2027 | LUSTIGMAN, SARA | reporter.nih.gov |
| Immune Pathophysiology of Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,589,657 | March 1, 2022 | December 31, 2028 | YAZDANBAKHSH, KARINA | reporter.nih.gov |
| Hormetic ER Stress Regulation of Hematopoietic Stem Cell Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,466,695 | July 3, 2021 | May 31, 2026 | LUCHSINGER, LARRY L | reporter.nih.gov |
| Transfusion-driven hyperhemolysis in sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,430,616 | September 1, 2023 | June 30, 2027 | AN, XIULI | reporter.nih.gov |
| Neighborhoods, Networks, and the HIV Care Continuum among HIV-infected MSM in NYC | NIH | National Institute of Mental Health | 2021 to 2022 | $1,835,699 | May 1, 2019 | February 29, 2024 | TIEU, HONG VAN NHU | reporter.nih.gov |
| Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,643,693 | February 15, 2013 | August 31, 2023 | DEBNATH, ASIM K | reporter.nih.gov |
| Red Cell Membrane Studies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1,269,424 | January 30, 1997 | July 31, 2024 | NARLA, MOHANDAS | reporter.nih.gov |
| Latexin function in the maintenance and regeneration of the hematopoietic system | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $854,000 | August 1, 2023 | July 31, 2026 | LIANG, YING | reporter.nih.gov |
| Transfusion-driven hyperhemolysis in sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2022 | $804,000 | September 13, 2022 | August 31, 2023 | AN, XIULI | reporter.nih.gov |
| Erythroblastic island macrophages in normal erythropoiesis and disordered erythropoiesis in polycythemia vera | NIH | National Heart, Lung, and Blood Institute | 2025 | $801,628 | August 1, 2025 | April 30, 2029 | AN, XIULI | reporter.nih.gov |
| Design of inhibitors targeted to the CD4 binding site on HIV - 1gp120 | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $777,449 | February 15, 2013 | March 31, 2025 | DEBNATH, ASIM K | reporter.nih.gov |
| The development of a recombinant vaccine against human onchocerciasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $775,846 | August 25, 2009 | February 29, 2024 | LUSTIGMAN, SARA | reporter.nih.gov |
| Use of forward Genetic approaches to identify Babesia receptors | NIH | National Heart, Lung, and Blood Institute | 2021 | $710,081 | December 15, 2017 | November 30, 2022 | LOBO, CHERYL ANN | reporter.nih.gov |
| Impact of geographic mobility on pre-exposure prophylaxis and HIV care outcomes | NIH | National Institute of Mental Health | 2024 to 2025 | $486,009 | September 1, 2024 | June 30, 2027 | TIEU, HONG VAN NHU | reporter.nih.gov |
| Influence of Social Networks on HIV Testing and PrEP Care among Young Latin American Gay, Bisexual, and Other Men Who Have Sex with Men | NIH | National Institute of Mental Health | 2025 | $485,131 | September 22, 2025 | September 21, 2027 | TIEU, HONG VAN NHU | reporter.nih.gov |
| Patrolling Monocytes in Sickle Pain Crisis and following Transfusion | NIH | National Heart, Lung, and Blood Institute | 2021 | $445,000 | July 15, 2019 | February 28, 2022 | YAZDANBAKHSH, KARINA | reporter.nih.gov |
| Mechanism of the short- and long-term effects of COVID-19-induced Alarmins on hematopoietic stem and progenitor cells. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $435,732 | July 1, 2023 | June 30, 2025 | LIANG, YING | reporter.nih.gov |
| Designing a Robust Platform for the In vitro Propagation of Babesia Microti in Human RBCs | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $427,000 | December 13, 2024 | November 30, 2027 | LOBO, CHERYL ANN | reporter.nih.gov |
| Rational design and evaluation of novel mRNA vaccines against MERS-CoV | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $339,869 | February 13, 2018 | May 31, 2021 | DU, LANYING | reporter.nih.gov |
| Effects of Exogenous Hormone Treatment on Vaccine Responses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $267,121 | December 16, 2024 | November 30, 2026 | LUSTIGMAN, SARA | reporter.nih.gov |
| Activating autophagy in filarial worms to identify novel macrofilaricides | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $258,750 | June 19, 2020 | May 31, 2023 | LUSTIGMAN, SARA | reporter.nih.gov |
| Evaluating accessory cells to improve homing and engraftment efficiency of CD34+ cells from sickle cell disease patients | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $256,200 | September 1, 2024 | July 31, 2026 | LIU, YUNFENG | reporter.nih.gov |
| Autophagic regulation of inflammasome-mediated hyperactive state in living macrophages | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $250,560 | July 12, 2021 | June 30, 2024 | MAGUPALLI, VENKAT GIRI | reporter.nih.gov |
| A Sequential Mixed Methods Study Evaluating the Influence of Violence on HIV Care and Viral Suppression among Young Black and Latinx MSM | NIH | National Institute of Mental Health | 2021 | $214,533 | July 1, 2020 | May 31, 2023 | TIEU, HONG VAN NHU | reporter.nih.gov |
| Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $213,500 | June 1, 2023 | May 31, 2025 | SHAO, BOJING | reporter.nih.gov |
| Development of a radiation countermeasure with sex-dependent radiation response. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $170,800 | July 15, 2025 | June 30, 2027 | LIANG, YING | reporter.nih.gov |
| Structural and Functional Alteration of host RBCs by Babesia | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $134,730 | December 13, 2024 | November 30, 2026 | BERI, DIVYA | reporter.nih.gov |
| Structure-based design of coronavirus subunit vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $102,509 | May 21, 2018 | May 31, 2021 | DU, LANYING | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 13 | $8,586,041 | 0 | $0 |
| 2024 | 8 | $6,945,551 | 0 | $0 |
| 2023 | 10 | $7,993,541 | 0 | $0 |
| 2022 | 8 | $7,986,143 | 0 | $0 |
| 2021 | 13 | $10,097,521 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 12 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 12 awards here |
Topics of its NIH awards
- Infectious Diseases
- Prevention
- Rare Diseases
- Biotechnology
- Hematology
- Emerging Infectious Diseases
- Clinical Research
- Genetics
- HIV/AIDS
- Vector-Borne Diseases
- Coronaviruses
- Immunization
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.